CMS Updates STI Screening and HIBC Coverage Policy (NCD 352) — What Billing Teams Need to Know

The Centers for Medicare & Medicaid Services has issued a modification to NCD 352, its national coverage determination governing screening for sexually transmitted infections and High-Intensity Behavioral Counseling (HIBC) to prevent STIs. This update affects how Medicare Part B covers chlamydia, gonorrhea, syphilis, and hepatitis B screening, as well as behavioral counseling services for qualifying patients. If your practice bills for preventive STI services under Medicare, this policy change warrants immediate review.

Field Detail
Payer CMS (Centers for Medicare & Medicaid Services)
Policy Screening for Sexually Transmitted Infections (STIs) and High-Intensity Behavioral Counseling (HIBC) to Prevent STIs
Policy Code NCD 352
Change Type Modified
Effective Date 2026-03-12
Impact Level Medium
Specialties Affected OB/GYN, Internal Medicine, Family Medicine, Infectious Disease, Preventive Medicine, Primary Care
Key Action Review patient eligibility criteria and documentation protocols for STI screening and HIBC services to ensure claims meet CMS medical necessity standards under the updated NCD.

What CMS NCD 352 Covers: STI Screening and Behavioral Counseling Under Medicare

NCD 352 establishes national coverage for STI screening and HIBC services under Medicare Part B's Additional Preventive Services benefit category, authorized under §1861(ddd) of the Social Security Act. Coverage applies to services that are reasonable and necessary for the prevention or early detection of illness or disability, carry a grade A or B recommendation from the United States Preventive Services Task Force (USPSTF), and are appropriate for Medicare Part A or Part B beneficiaries.

CMS has determined that the evidence is adequate to support coverage for the following:

Coverage for these services has been in effect since November 8, 2011, for claims with dates of service on or after that date. The March 2026 modification updates the policy's terms — billing teams should review the full updated document to identify any changes to eligibility criteria, frequency limits, or documentation requirements that may affect claims going forward.


Medical Necessity Criteria: Who Qualifies Under NCD 352

CMS coverage under this NCD is directly tied to USPSTF grade A and B recommendations. That means your documentation needs to support the patient's eligibility based on specific clinical and demographic criteria — not just a general order for STI testing.

For chlamydia and gonorrhea screening, increased risk for older women (age 25 and above) must be documented. Risk factors typically include new or multiple sexual partners, inconsistent condom use, prior STI history, or other clinically recognized indicators. For syphilis screening, increased risk criteria apply to all non-pregnant persons — documentation should reflect the clinical basis for that determination.

Hepatitis B screening has a defined trigger point: the first prenatal visit. Claims billed outside that context may face scrutiny. For HIBC services, the policy covers all sexually active adolescents automatically, while adults require documented increased risk for STIs.

The underlying laboratory tests must use FDA-approved or FDA-cleared methods. If your lab or reference lab is using a test that hasn't received FDA clearance for the specific indication, that's a denial risk worth addressing in advance.


HIBC for STI Prevention: What "High-Intensity" Actually Means for Billing

High-Intensity Behavioral Counseling is a specific service type — it is not the same as a brief screening conversation documented in a preventive visit note. Under USPSTF definitions and CMS coverage intent, HIBC involves structured, intensive counseling sessions focused on reducing STI risk behaviors.

This distinction matters for billing. If your clinicians are providing counseling that meets the threshold for HIBC, it needs to be documented and billed accordingly. Underdocumented HIBC services are frequently denied or downcoded because the clinical record doesn't reflect the intensity, duration, or behavioral intervention elements that justify the service.

For adolescent patients, no increased-risk documentation is required — coverage applies to all sexually active adolescents. For adults, the chart must support the increased-risk determination that triggers eligibility.


Coverage Basis: The USPSTF-CMS Link Billing Teams Must Understand

CMS coverage under §410.64 is explicitly contingent on USPSTF grade A or B recommendations. This is not incidental — it's the statutory mechanism that activates coverage. When a USPSTF recommendation changes its grade (upward or downward), it can directly affect whether CMS covers a service, which is one reason NCDs in this category get modified over time.

For billing teams, this means two things. First, the clinical indication documented in the record needs to align with the USPSTF-recommended population. Second, when you see an NCD modification like this one, it's worth checking whether the underlying USPSTF recommendations have been updated — because the NCD may be responding to a recommendation change that affects which patient populations are now in or out of coverage.

No prior authorization requirement is specified in this NCD. These services are covered preventive benefits under Part B, which means the access barrier is documentation and medical necessity — not an upfront auth process.


Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
Re-review every 24 monthsRe-review every 12 months with updated clinical documentation

Affected Codes

This policy does not list specific CPT, HCPCS, or ICD-10 codes in the data provided for this version of NCD 352. CMS's published NCD may reference applicable laboratory and counseling codes; billing teams should consult the full policy document and the CMS Coverage Database directly to identify the current applicable codes for STI screening lab tests and HIBC services. Coding lookups should also cross-reference your Medicare Administrative Contractor (MAC) for any local guidance that supplements this NCD.


This policy is now in effect (since 2026-03-12). Verify your claims match the updated criteria above.

What Your Billing Team Should Do

#Action Item
1

Pull and review the full updated NCD 352 text before March 12, 2026. Compare the modified version against any internal billing policies or documentation templates your practice currently uses for STI screening and HIBC. Identify any criteria that have changed and flag them for your clinical documentation team before the effective date.

2

Audit recent claims for documentation completeness. For patients billed under this policy — particularly adult women receiving chlamydia or gonorrhea screening and adults receiving HIBC — verify that the medical record explicitly documents increased risk. Vague or absent risk documentation is the most common reason these claims fail.

3

Confirm FDA approval status of all STI laboratory tests in use. Work with your lab or reference lab to obtain written confirmation that tests used for chlamydia, gonorrhea, syphilis, and HBV screening carry the appropriate FDA clearance for the billed indication. Document this in your compliance file.

+ 2 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee